ANUPAMRASAYANINDIA / Q3-FY26 / claim-ledger

Audit the questions that mattered.

Anupam Rasayan India · Analyst questions, management answers, and the quality of the response where the ledger is available.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ3-FY26 · 2026-02-10Back to quarter ↗

Questions audited

Answered directly

90%

Numeric claims

Consistency

—

Question ledger

What was answered, and how?

Tanya Chadri · Invest Tech

direct

EPS impact from J-Hawk acquisition this quarter

Right now we have not yet consolidated the numbers as the transaction is yet to be completed and hence no contribution of the J-Hawk's revenue or profit has been added to this quarter's results.

Harsha · MK Global

direct

Strategic plans with the acquired asset

We get a critical manufacturing asset base in US, a large part of revenue from US and performance material business into semiconductors, aerospace, pharma, EV, etc. Also strong cube technologies and validation with high-end customers.

Disha Shamir Maheshwari · N Shiv

direct

Why Anupam was preferred for LiPF6 over global players

Offering a full supply chain coupled with technical capabilities of multiple chemistries at scale, and long-term relationship with the customer.

Disha Shamir Maheshwari · N Shiv

partial

Why European partners selected Anupam for LiPF6 despite China pricing

Every customer needs a strong credible supply chain solution, not just import and process. Also chemistry capability to optimize cost as scale up. We also have a US partner, not just European.

Siddhin Natan · JM Financial

direct

Working capital days improvement and targets for FY27 and FY28

As of now we are around about 250 odd days and we expect that in the near term we should be going towards 220 and as you said 27 I think 27 we should be below 200 around 180 days or below.